Press release
Global Deep Brain Stimulation Devices Market is Anticipated to be Worth US$9.4 bn by the end of 2020
The vendor landscape of the global deep brain stimulation devices market for Parkinson’s disease includes giants such as Boston Scientific, Aleva Neurotherapeutics SA, Medtronic Inc., and St. Jude Medical Inc. The market players are increasingly outsourcing the manufacturing of DBS devices to contract manufacturing organizations (CMOs).Furthermore, the market players are targeting emerging economies in regions such as Asia Pacific by improving public awareness about Parkinson’s disease, its consequences, treatment options, and associated benefits of DBS devices, a new Transparency Market Research report states. “Improving the product life and reducing the prices of DBS devices would create better prospects for the market players,” a TMR analyst recommends.
Obtain Report Details @ https://www.transparencymarketresearch.com/deep-brain-stimulator-market.html
Geriatric Population Represents Key Target Market for DBS Devices
Rapidly growing geriatric population has led to the high prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, dementia, and others. This is one of the key factors driving the growth of the global DBS devices market for Parkinson’s disease. Neurological disorders are one of the major causes of mortality and are responsible for around 12% of deaths every year across the globe. Parkinson’s disease is the most prevalent neurological disorder after Alzheimer’s disease.
Though drug therapy is termed as the most effective treatment option to control the initial stages of Parkinson’s disease, surgical treatment using DBS devices is effective in the later stages of the disease. Patients and physicians increasingly prefer minimally invasive procedures for the treatment of Parkinson’s disease. The availability of technologically advanced DBS devices, coupled with favorable reimbursement scenario has led to the increased acceptance of DBS devices worldwide.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
However, the risks associated with deep brain stimulation procedures might play spoilsport in the growth of the market. The implementation of certain government policies such as the Affordable Care Act in the U.S. would negatively impact the market’s growth during the forecast period. “The presence of a large patient pool across the emerging economies is expected to create new growth opportunities for the market,” a TMR analyst states.
Progressive Increase in New Cases of Parkinson’s Disease Puts New Opportunities in Focus
Among the key regions in the global DBS devices market for Parkinson’s disease, North America has been a major market owing to the growing prevalence of the disease. According to the Parkinson’s Disease Foundation, about 10 mn people worldwide suffer from this condition and over 1 mn of these patients are in the U.S. Around 60,000 new cases of Parkinson’s disease are diagnosed every year in the region. Furthermore, the growing awareness of the disease has propelled the growth of the regional DBS devices market.
Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=432
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Deep Brain Stimulation Devices Market is Anticipated to be Worth US$9.4 bn by the end of 2020 here
News-ID: 875936 • Views: …
More Releases from Transparency Market Research
Global n-Butyl Acetate Market Expected to Reach US$ 1.7 Billion by 2034, Driven …
n-Butyl acetate is a versatile organic ester used primarily as a solvent due to its excellent solvency, moderate evaporation rate, and compatibility with various chemical systems. It is integral to automotive refinishing, industrial coatings, wood finishes, and consumer-grade products such as nail lacquers. As industries worldwide prioritize efficiency and regulatory compliance, n-butyl acetate offers an effective balance between performance and environmental standards, making it a preferred choice for manufacturers. Growing…
Nematicide Market to Reach US$ 1.9 Billion by 2034, Driven by Rising Global Food …
The global nematicide market continues to gain strategic importance as agriculture faces intensifying pressure from climate change, soil degradation, and rising global food demand. Nematicides-chemical or biological agents designed to manage destructive plant-parasitic nematodes-play a critical role in safeguarding crop yields, improving soil health, and supporting sustainable farming practices. In recent years, farmers, agronomists, and global agriculture companies have increasingly recognized the economic losses caused by nematodes across a wide…
North America Home Storage Market Size, Share, Growth Forecast to 2034 - Industr …
The North America Home Storage Market has emerged as a rapidly evolving segment driven by shifting lifestyle patterns, rising residential construction, and growing consumer interest in organized living spaces. The market was valued at US$ 45.5 Bn in 2023 and is projected to expand at a CAGR of 5.0% from 2024 to 2034, reaching US$ 76.6 Bn by 2034. The region's increasing urbanization, shrinking living spaces in metropolitan cities, and…
Nephropathic Cystinosis Treatment Market Forecast to Grow to US$ 744.3 Million b …
The nephropathic cystinosis treatment market is undergoing a period of dynamic transformation as advancements in therapeutic strategies and rare disease awareness continue to shape global healthcare priorities. Characterized by its ultrarare prevalence and life-long impact, nephropathic cystinosis demands consistent clinical management beginning in infancy. This has encouraged major healthcare institutions and pharmaceutical companies to explore innovative treatment approaches that enhance patient outcomes while addressing unmet medical needs. As regulatory bodies…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…
